Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jan;27(1):88–91. doi: 10.1111/j.1365-2125.1989.tb05339.x

The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis.

A I Mallet 1, P Norris 1, N B Rendell 1, E Wong 1, M W Greaves 1
PMCID: PMC1379709  PMID: 2495814

Abstract

Treatment of four mastocytosis patients with the mast cell stabilising drugs, disodium cromoglycate and ketotifen failed to alter significantly the urinary excretion levels of histamine or N tau-methylimidazole acetic acid. No clinical improvement was noted in any subject after treatment by either drug.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craps L. P., Ney U. M. Ketotifen: current views on its mechanism of action and their therapeutic implications. Respiration. 1984;45(4):411–421. doi: 10.1159/000194648. [DOI] [PubMed] [Google Scholar]
  2. Frieri M., Alling D. W., Metcalfe D. D. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med. 1985 Jan;78(1):9–14. doi: 10.1016/0002-9343(85)90454-1. [DOI] [PubMed] [Google Scholar]
  3. Grandel K. E., Farr R. S., Wanderer A. A., Eisenstadt T. C., Wasserman S. I. Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med. 1985 Aug 15;313(7):405–409. doi: 10.1056/NEJM198508153130702. [DOI] [PubMed] [Google Scholar]
  4. Heavey D. J., Kobza-Black A., Barrow S. E., Chappell C. G., Greaves M. W., Dollery C. T. Prostaglandin D2 and histamine release in cold urticaria. J Allergy Clin Immunol. 1986 Sep;78(3 Pt 1):458–461. doi: 10.1016/0091-6749(86)90033-3. [DOI] [PubMed] [Google Scholar]
  5. Huston D. P., Bressler R. B., Kaliner M., Sowell L. K., Baylor M. W. Prevention of mast-cell degranulation by ketotifen in patients with physical urticarias. Ann Intern Med. 1986 Apr;104(4):507–510. doi: 10.7326/0003-4819-104-4-507. [DOI] [PubMed] [Google Scholar]
  6. James J., Warin R. P. Factitious wealing at the site of previous cutaneous response. Br J Dermatol. 1969 Dec;81(12):882–884. doi: 10.1111/j.1365-2133.1969.tb15968.x. [DOI] [PubMed] [Google Scholar]
  7. Roberts L. J., 2nd, Aulsebrook K. A., Oates J. A. Comparative evaluation of the radioenzymatic method for the determination of urinary histamine with a mass spectrometric assay. J Chromatogr. 1985 Feb 27;338(1):41–49. doi: 10.1016/0378-4347(85)80068-2. [DOI] [PubMed] [Google Scholar]
  8. Roberts L. J., 2nd, Sweetman B. J., Lewis R. A., Austen K. F., Oates J. A. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med. 1980 Dec 11;303(24):1400–1404. doi: 10.1056/NEJM198012113032405. [DOI] [PubMed] [Google Scholar]
  9. Schwartz L. B., Metcalfe D. D., Miller J. S., Earl H., Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987 Jun 25;316(26):1622–1626. doi: 10.1056/NEJM198706253162603. [DOI] [PubMed] [Google Scholar]
  10. Soter N. A., Austen K. F., Wasserman S. I. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med. 1979 Aug 30;301(9):465–469. doi: 10.1056/NEJM197908303010903. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES